Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs.

John Henry McDermottVideha SharmaWilliam G NewmanPaul WilsonKatherine PayneStuart Wright

Published in: British journal of clinical pharmacology (2024)

This study identifies public preferences for a pharmacogenetic testing service and demonstrates how predicted uptake can be impacted by relatively minor adaptations. This highlights areas for prioritization during development of future pharmacogenetic services.

Keyphrases

healthcare
mental health
decision making
primary care
patient safety
genome wide
high intensity
emergency department
gene expression
drug induced